Prognosis
Diabetes Drugs Latest to Be Targeted for Carcinogen Scrutiny
- FDA testing medications as EU asks companies for screening
- Patients urged to continue taking drugs pending further study
This article is for subscribers only.
Global health regulators are looking into whether widely used diabetes drugs may contain unsafe levels of a carcinogen that has previously been found in heart and gastric medications.
The U.S. Food and Drug Administration said in a statement Wednesday that the agency is testing samples of metformin sold in the U.S. for NDMA, and that it will recommend recalls of the medication as appropriate. Metformin is widely prescribed to patients when they are initially treated for type 2 diabetes.